Collaboration Results Clause Samples

Collaboration Results. Subject to the terms and conditions of this Agreement, (a) Arrowhead will own all Arrowhead Collaboration Results, (b) Amgen will own all Amgen Collaboration Results, and (c) each Party will jointly own all Joint Collaboration Results. Except as otherwise provided in this Agreement, each Party shall have the right to use and exploit the Joint Collaboration Results for any purpose without the duty of accounting or seeking consent from the other Party. Each Party shall notify the other Party promptly after developing any Collaboration Results of which the other Party is the owner. Each Party shall assign and hereby assigns to the other Party its entire right, title and interest in and to the Collaboration Results and all intellectual property rights therein as needed to implement the ownership of the Collaboration Results in accordance with the provisions of this Section 2.7.
Collaboration Results. Once each Calendar Quarter Ginkgo will provide reports on its technical progress relating to the Development and Scale Up of Target Cannabinoids under all existing TDPs to the JSC. Such reports will include supporting documents, such as laboratory records, test results, plans, and other data that may reasonably be requested by the JSC. Any information disclosed by Ginkgo to Cronos pursuant to this Section 2.9 shall be considered Confidential Information of Ginkgo and may be used only in accordance with rights expressly granted under this Agreement. The JSC may also agree to other meetings or other conferences as deemed reasonably necessary by members of the JSC.
Collaboration Results. Subject to the option rights of Bracco with regard to the Other Therapeutic Field as set forth in Section 4.3, Bracco grants to Dyax an exclusive worldwide license, with the right to sublicense, to the Collaboration Results generated by Bracco for all uses outside of the Collaboration Field. Should Dyax obtain rights with regard to any Dyax Lead in the Diagnostic Imaging Field pursuant to Section 5.2 or to any Dyax Lead or Collaboration Lead in the Collaboration Field pursuant Section 5.3, Dyax shall have an exclusive worldwide license, with the right to sublicense, to the specific Collaboration Results pertaining to the applicable Collaboration Lead and a nonexclusive worldwide license, with the right to sublicense, to use the generally useful Collaboration Results in connection therewith. Dyax's rights to the Collaboration Lead and the Collaboration Results in the Collaboration Field shall be subject to the diligence requirements of Section 5.5.
Collaboration Results. The Vermont PCO and OMH coordinate closely in efforts to further meet the needs of both of these specific populations. To address the migrant farmworker population’s needs the PCO and OMH have worked with the Bi-State Primary Care Association and several FQHCs to create the Vermont Farm Health Connection, which conducts health outreach and screenings to migrant dairy farmworkers in several counties. Vermont dairies are large, highly mechanized operations. Migrant workers typically reside on the grounds of these farms and work as many as 70 hours in a six-day workweek. This leaves limited time for seeking access to needed health services. The Vermont Farm Health Connection is supported in part by a grant from the federal Office of Rural Health Policy. It provides work safety, nutrition education, and basic health education to farmworkers, many of whom come from rural farming communities in Mexico. Additionally, the PCO and OMH have coordinated with the University of Vermont to establish health outreach to seasonal farmworkers in the state’s fruit and apple orchards. This effort provides primary care, health education, and screening services to migrant farmworkers. Staff with Spanish-language skills provide the services. This effort supplements the work of FQHCs, which do not currently have the capacity to provide these targeted services. To focus on the needs of the diverse immigrant populations the PCO and OMH have worked with Vermont’s Comprehensive Cancer Control program to arrange breast and cervical cancer screening services for immigrant women in the Burlington area. As part of this effort, an FQHC conducts community outreach to immigrant women between ages 40-65 from 12 different cultural and language groups. Promotoras—lay Hispanic or Latino community members who have received training to provide basic health education in their communities—who are familiar with the different groups conduct outreach and education activities. Where necessary, call-in translation services are utilized. Women participating in the program return repeatedly for the FQHC’s services. Although they both have limited resources, the Vermont PCO and OMH, have been able to meet the health needs of migrant workers, refugees, and immigrants in the state by working with external partners. This is a successful model for smaller states with relatively small budgets.
Collaboration Results. Arrowhead shall not publicly disclose any Collaboration Results without the express written consent of Amgen, which consent may be granted or withheld in Amgen’s sole discretion.
Collaboration Results. Tango shall maintain, and shall cause its Affiliates and their respective employees and permitted subcontractors to maintain, records regarding its or their conduct of activities under the Research Collaboration, which may be in the form of electronic lab notebooks that are segregated from other activities not performed under this Agreement, for so long as necessary after the applicable activity to comply with Applicable Laws or to support the prosecution, maintenance and enforcement of intellectual property rights (including Patent Rights) in accordance with Article 8, and as necessary in order to comply with its obligations under this Agreement, regarding its conduct of the Research Collaboration, but in no event less than [***]. Such records shall be maintained in sufficient detail and in good scientific manner appropriate for patent and regulatory purposes (and as otherwise necessary to comply with its obligations under this Agreement) and shall reflect the work done by or on behalf of Tango in the performance of the Research Collaboration, including all Collaboration Results. During such record retention period, Gilead shall have the right, during normal business hours and upon reasonable notice not more than [***], to inspect and copy Collaboration Results.
Collaboration Results. During the Research Term, for each Collaboration Target, Molecular Partners shall not publicly disclose any Collaboration Results related directly to AGN DARPin Domains or Product Candidates for such Collaboration Target, provided that the foregoing shall not apply to any MP DARPin Domains, any AGN DARPin Domains that are replaced, or any Collaboration Results related to AGN DARPin Domains or Product Candidates for Collaboration Targets that are replaced (and are no longer Collaboration Targets). During
Collaboration Results 

Related to Collaboration Results

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Research Program The term “

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.